Please login to the form below

Not currently logged in
Email:
Password:

Fresenius Kabi

This page shows the latest Fresenius Kabi news and features for those working in and with pharma, biotech and healthcare.

Data integrity scuppers Fresenius deal with Akorn

Data integrity scuppers Fresenius deal with Akorn

German healthcare group Fresenius Kabi has abandoned plans to acquire US generic and over-the-counter drugmaker Akorn in a $4.3bn deal, citing FDA compliance issues. ... Fresenius raised the data integrity question and said it was launching an

Latest news

More from news
Approximately 3 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    It is encouraging, therefore, to see Fresenius’s share price increase by 2% following the announcement that its subsidiary Fresenius Kabi is making two acquisitions worth over $5.5bn. ... Fresenius will pay Merck a single digit royalty on sales.

  • Pharma deals during March 2013 Pharma deals during March 2013

    39.5. Goa Formulations/ Fresenius Kabi India. Acquisition. Manufacturer of drugs including intravenous fluids.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Hikma appoints group scientific officer and global head of R&D Hikma appoints group scientific officer and global head of R&D

    Hikma appoints group scientific officer and global head of R&D. Dr Surendera Tyagi joins the pharma group from Fresenius Kabi. ... He joins the pharma group from Fresenius Kabi, where he most recently led its US innovation and development centre.

  • Bartenbach adds to healthcare management team Bartenbach adds to healthcare management team

    Bartenbach adds to healthcare management team. Anja Treiber has worked with CSL Behring, Novo Nordisk, Fresenius Kabi and Merz Pharma. ... In the last two years, Treiber has focused on international pharma clients including CSL Behring, Novo Nordisk,

  • Par hires Antonio Pera as commercial head Par hires Antonio Pera as commercial head

    His positions prior to joining JHP include senior VP, supply chain management at AmerisourceBergen Corporation, and senior management positions at Fresenius Kabi Pharmaceuticals, Oakwood Laboratories and Bedford Laboratories. “

  • Biotest makes two senior management appointments Biotest makes two senior management appointments

    Biotest makes two senior management appointments. Promotion for Jörg Schüttrumpf while Markus Rothenburger joins from Fresenius Kabi. ... Prof Rothenburger joins Biotest from his role as VP medical and clinical affairs at Fresenius Kabi.

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics